OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.18−0.18 (-12.96%)
Close on Nov 16, 2026Market cap $61.66MP/E –Yield –
OKYO Pharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
OKYO Pharma's total debt was $2.70M at Mar 31, 2025. For fiscal 2025 it was $2.70M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.70M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $2.70M | – |
See a number that looks wrong?